![](https://geistlich.us/wp-content/uploads/clinical-case-bg.jpg)
CLINICAL CASE
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_1.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_2.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_3.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_4.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_5.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_6.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_7.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_8.jpg)
![](https://geistlich.us/wp-content/uploads/5-schulze-spate_9.jpg)
Download our new eBook and learn how to 4C predictability
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
Geistlich unveils vallos®, a full line of allograft granules and fibers. Discover vallos®